In 2023, DNA/RNA medicine approvals reached a record high, and the FDA approved a wide array of new therapies that will improve the well-being of patients.
Vaccine developers are facing an especially difficult venture financing market despite the success investors have had with Covid-19 vaccine developers Moderna and BioNTech
wsj.com/articles/vaccine-sta…
🧬🧡 Did you know that 1 in 20 people will live with a rare disease at some point in their life? Let's use February to educate, advocate, and stand in solidarity with the rare disease community. 🌍💙 #FebruaryAwareness
In honor of Black History Month, meet a few Black pioneers in STEM – and learn why advancing representation in the life sciences is so important.
Learn more: bio.news/latest-news/black-h…
❤️ February is Heart Awareness Month! Let's give precedence to cardiovascular health and promote awareness regarding the prevention of illnesses. Small lifestyle changes can make a big impact. Join the journey to a healthier heart! #HeartHealth#HeartAwarenessMonth ❤️🏥
Great news. House Ways & Means approves restoration of R&D tax credit
In a 40-3 bipartisan vote. Thanks to @IAmBiotech for leadership on this. Bill awaits a full House vote. Important: ask your lawmakers to support action.bio.org/HMv3Th4$XBI
BIO Members receive exclusive discounts at all of our industry events, including the BIO CEO & Investor Conference in New York, taking place February 26th through the 27th. Learn more today: bcic.bio.org/?_gl=1*1yepzgl*…
Our CEO Rachel King's op-ed exposes the danger of short-sighted U.S. policies, risking future medical breakthroughs. Government interference threatens life-changing drugs. Stay informed on #biotech innovation impact and preserve the progress made thus far. 💊🔬✨ @RachelKingBiomarketwatch.com/story/how-go…
Small R&D-intensive companies are facing a significant reduction in capital due to a new policy that disallows immediate expensing of research expenses. Your support is needed to help restore this important deduction. Act now. action.bio.org/HMv3Th4?p2aso…
Unleashing the Power of Biotech: The world of biotechnology is an exciting place to be. From creating novel therapies to building sustainable solutions, our members are at the forefront of innovation. Together, we are transforming lives, communities, and economies. Become a BIO member today! bio.org/become-bio-member
A new op-ed from Bio’s Chair, Ted Love, discusses how a minor reform to the #IRA can bring hope to #patients living with rare diseases. Read more: realclearhealth.com/blog/202…
I am proud that biotechnology can contribute to achieving sustainable development goals. Biotech is essential! Read more here: bio.news/international/repor…
Protecting intellectual property rights is crucial for maintaining US competitiveness and national security. Slashing IP rights undermines innovation and puts our economy at risk. BIO's @JAMurphy_III weighs in on the importance of protecting biotech IP. #IPsecurity#Biotechnology#Innovationthehill.com/opinion/4386979-…
Today, a self-proclaimed 'unintentional entrepreneur' joined BIO staff for the first time. Our new CEO John Crowley spoke about what biotech means to him, his vision for BIO, and the potential of our industry. It was great to welcome him! #IamBIO
While embracing the dynamic energy of NOLA, we dove into thoughtful dialogues on biotech advancements at #CSBA. As a collective, we're exploring effective strategies for fostering unity and collaboration in our journey towards innovation. #TeamworkMakesTheDreamWork